The potential link between hypomagnesemia and glucose intolerance, especially in the context of diabetes mellitus, warrants further investigation. SGLT2 inhibitors, established for their role in diabetes management, are associated with a significant increase in serum magnesium concentration among diabetic patients [2]. Here, SLC5A2 is linked to diabetes mellitus.